Denne situation påvirker naturligvis medicinalindustrien og myndighederne, men det er patienterne, der i første omgang berøres, for disse komplekse procedurer forhindrer dem i at drage fordel af bedre lægemidler. ###>Of course, this situation affects the pharmaceutical industry and authorities, but it is patients who are primarily affected because these complex procedures delay them receiving the benefits of improved medicines.